| Symbol |
Name |
|
ABL1
|
ABL proto-oncogene 1, non-receptor tyrosine kinase
|
|
AKT1
|
v-akt murine thymoma viral oncogene homolog 1
|
|
AKT2
|
v-akt murine thymoma viral oncogene homolog 2
|
|
ALK
|
anaplastic lymphoma receptor tyrosine kinase
|
|
APBB1
|
amyloid beta (A4) precursor protein-binding, family B, member 1 (Fe65)
|
|
AQP5
|
aquaporin 5
|
|
ARAF
|
A-Raf proto-oncogene, serine/threonine kinase
|
|
ARHGAP5
|
Rho GTPase activating protein 5
|
|
ATF1
|
activating transcription factor 1
|
|
ATF2
|
activating transcription factor 2
|
|
BAD
|
BCL2-associated agonist of cell death
|
|
BCAR1
|
breast cancer anti-estrogen resistance 1
|
|
BCR
|
breakpoint cluster region
|
|
BRAF
|
B-Raf proto-oncogene, serine/threonine kinase
|
|
CASP9
|
caspase 9, apoptosis-related cysteine peptidase
|
|
CBL
|
Cbl proto-oncogene, E3 ubiquitin protein ligase
|
|
CCND1
|
cyclin D1
|
|
CCNE1
|
cyclin E1
|
|
CD200R1
|
CD200 receptor 1
|
|
CDC73
|
cell division cycle 73
|
|
CDH5
|
cadherin 5, type 2 (vascular endothelium)
|
|
CDKN1A
|
cyclin-dependent kinase inhibitor 1A (p21, Cip1)
|
|
CDKN1B
|
cyclin-dependent kinase inhibitor 1B (p27, Kip1)
|
|
CEBPA
|
CCAAT/enhancer binding protein (C/EBP), alpha
|
|
CEBPB
|
CCAAT/enhancer binding protein (C/EBP), beta
|
|
CFL1
|
cofilin 1 (non-muscle)
|
|
CREB1
|
cAMP responsive element binding protein 1
|
|
CRK
|
v-crk avian sarcoma virus CT10 oncogene homolog
|
|
CRKL
|
v-crk avian sarcoma virus CT10 oncogene homolog-like
|
|
CRYAB
|
crystallin, alpha B
|
|
CSF1R
|
colony stimulating factor 1 receptor
|
|
CSF2RB
|
colony stimulating factor 2 receptor, beta, low-affinity (granulocyte-macrophage)
|
|
CSF3R
|
colony stimulating factor 3 receptor (granulocyte)
|
|
CSK
|
c-src tyrosine kinase
|
|
CTNND1
|
catenin (cadherin-associated protein), delta 1
|
|
DAB2
|
Dab, mitogen-responsive phosphoprotein, homolog 2 (Drosophila)
|
|
DAPP1
|
dual adaptor of phosphotyrosine and 3-phosphoinositides
|
|
DOK1
|
docking protein 1, 62kDa (downstream of tyrosine kinase 1)
|
|
EGFR
|
epidermal growth factor receptor
|
|
EIF2AK2
|
eukaryotic translation initiation factor 2-alpha kinase 2
|
|
EIF2S1
|
eukaryotic translation initiation factor 2, subunit 1 alpha, 35kDa
|
|
ELK1
|
ELK1, member of ETS oncogene family
|
|
ELK3
|
ELK3, ETS-domain protein (SRF accessory protein 2)
|
|
EPHA8
|
EPH receptor A8
|
|
ERBB2
|
erb-b2 receptor tyrosine kinase 2
|
|
ERF
|
Ets2 repressor factor
|
|
ESR1
|
estrogen receptor 1
|
|
ESR2
|
estrogen receptor 2 (ER beta)
|
|
ETS1
|
v-ets avian erythroblastosis virus E26 oncogene homolog 1
|
|
ETS2
|
v-ets avian erythroblastosis virus E26 oncogene homolog 2
|
|
ETV6
|
ets variant 6
|
|
EZR
|
ezrin
|
|
FGFR1
|
fibroblast growth factor receptor 1
|
|
FGFR2
|
fibroblast growth factor receptor 2
|
|
FOS
|
FBJ murine osteosarcoma viral oncogene homolog
|
|
FOSL1
|
FOS-like antigen 1
|
|
FOXO1
|
forkhead box O1
|
|
FOXO4
|
forkhead box O4
|
|
FYN
|
FYN proto-oncogene, Src family tyrosine kinase
|
|
G3BP1
|
GTPase activating protein (SH3 domain) binding protein 1
|
|
GAB1
|
GRB2-associated binding protein 1
|
|
GATA6
|
GATA binding protein 6
|
|
GRB2
|
growth factor receptor-bound protein 2
|
|
GSK3A
|
glycogen synthase kinase 3 alpha
|
|
GSK3B
|
glycogen synthase kinase 3 beta
|
|
GTF2I
|
general transcription factor IIi
|
|
H2AFX
|
H2A histone family, member X
|
|
HRAS
|
Harvey rat sarcoma viral oncogene homolog
|
|
IFI16
|
interferon, gamma-inducible protein 16
|
|
IL2RB
|
interleukin 2 receptor, beta
|
|
IL6ST
|
interleukin 6 signal transducer
|
|
INPP5D
|
inositol polyphosphate-5-phosphatase, 145kDa
|
|
INSR
|
insulin receptor
|
|
IRS1
|
insulin receptor substrate 1
|
|
JUN
|
jun proto-oncogene
|
|
KAT5
|
K(lysine) acetyltransferase 5
|
|
KHDRBS1
|
KH domain containing, RNA binding, signal transduction associated 1
|
|
KIT
|
v-kit Hardy-Zuckerman 4 feline sarcoma viral oncogene homolog
|
|
KRAS
|
Kirsten rat sarcoma viral oncogene homolog
|
|
KSR1
|
kinase suppressor of ras 1
|
|
KSR2
|
kinase suppressor of ras 2
|
|
LAT
|
linker for activation of T cells
|
|
LCK
|
LCK proto-oncogene, Src family tyrosine kinase
|
|
LCP2
|
lymphocyte cytosolic protein 2 (SH2 domain containing leukocyte protein of 76kDa)
|
|
LRRK2
|
leucine-rich repeat kinase 2
|
|
MAP2K1
|
mitogen-activated protein kinase kinase 1
|
|
MAP2K2
|
mitogen-activated protein kinase kinase 2
|
|
MAPK1
|
mitogen-activated protein kinase 1
|
|
MAPK14
|
mitogen-activated protein kinase 14
|
|
MAPK3
|
mitogen-activated protein kinase 3
|
|
MAPK7
|
mitogen-activated protein kinase 7
|
|
MAPK8
|
mitogen-activated protein kinase 8
|
|
MAPKAPK2
|
mitogen-activated protein kinase-activated protein kinase 2
|
|
MAPKAPK5
|
mitogen-activated protein kinase-activated protein kinase 5
|
|
MAPT
|
microtubule-associated protein tau
|
|
MAX
|
MYC associated factor X
|
|
MDM2
|
MDM2 proto-oncogene, E3 ubiquitin protein ligase
|
|
MECOM
|
MDS1 and EVI1 complex locus
|
|
MET
|
MET proto-oncogene, receptor tyrosine kinase
|
|
MLLT4
|
myeloid/lymphoid or mixed-lineage leukemia (trithorax homolog, Drosophila); translocated to, 4
|
|
MPL
|
MPL proto-oncogene, thrombopoietin receptor
|
|
MSN
|
moesin
|
|
MTOR
|
mechanistic target of rapamycin (serine/threonine kinase)
|
|
MYB
|
v-myb avian myeloblastosis viral oncogene homolog
|
|
MYC
|
v-myc avian myelocytomatosis viral oncogene homolog
|
|
MYL9
|
myosin, light chain 9, regulatory
|
|
NDRG1
|
N-myc downstream regulated 1
|
|
NF1
|
neurofibromin 1
|
|
NF2
|
neurofibromin 2 (merlin)
|
|
NFKBIA
|
nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, alpha
|
|
NTRK1
|
neurotrophic tyrosine kinase, receptor, type 1
|
|
NTRK2
|
neurotrophic tyrosine kinase, receptor, type 2
|
|
OSTF1
|
osteoclast stimulating factor 1
|
|
OTUB1
|
OTU deubiquitinase, ubiquitin aldehyde binding 1
|
|
PAG1
|
phosphoprotein membrane anchor with glycosphingolipid microdomains 1
|
|
PAK1
|
p21 protein (Cdc42/Rac)-activated kinase 1
|
|
PAK4
|
p21 protein (Cdc42/Rac)-activated kinase 4
|
|
PDGFRA
|
platelet-derived growth factor receptor, alpha polypeptide
|
|
PDGFRB
|
platelet-derived growth factor receptor, beta polypeptide
|
|
PHB
|
prohibitin
|
|
PIK3R1
|
phosphoinositide-3-kinase, regulatory subunit 1 (alpha)
|
|
PLA2G4A
|
phospholipase A2, group IVA (cytosolic, calcium-dependent)
|
|
PLCG1
|
phospholipase C, gamma 1
|
|
PLD2
|
phospholipase D2
|
|
POU1F1
|
POU class 1 homeobox 1
|
|
PRKCA
|
protein kinase C, alpha
|
|
PRKCB
|
protein kinase C, beta
|
|
PRKCD
|
protein kinase C, delta
|
|
PRKCI
|
protein kinase C, iota
|
|
PRKCQ
|
protein kinase C, theta
|
|
PRKCZ
|
protein kinase C, zeta
|
|
PRKD1
|
protein kinase D1
|
|
PRKD3
|
protein kinase D3
|
|
PRKDC
|
protein kinase, DNA-activated, catalytic polypeptide
|
|
PTK2
|
protein tyrosine kinase 2
|
|
PTK2B
|
protein tyrosine kinase 2 beta
|
|
PTPN11
|
protein tyrosine phosphatase, non-receptor type 11
|
|
PTPN12
|
protein tyrosine phosphatase, non-receptor type 12
|
|
PTPN3
|
protein tyrosine phosphatase, non-receptor type 3
|
|
PTPRA
|
protein tyrosine phosphatase, receptor type, A
|
|
PTPRB
|
protein tyrosine phosphatase, receptor type, B
|
|
PTPRE
|
protein tyrosine phosphatase, receptor type, E
|
|
PTPRH
|
protein tyrosine phosphatase, receptor type, H
|
|
PTPRO
|
protein tyrosine phosphatase, receptor type, O
|
|
PXN
|
paxillin
|
|
RAB24
|
RAB24, member RAS oncogene family
|
|
RAF1
|
Raf-1 proto-oncogene, serine/threonine kinase
|
|
RALA
|
v-ral simian leukemia viral oncogene homolog A (ras related)
|
|
RAP1A
|
RAP1A, member of RAS oncogene family
|
|
RAP1B
|
RAP1B, member of RAS oncogene family
|
|
RAPGEF1
|
Rap guanine nucleotide exchange factor (GEF) 1
|
|
RASA1
|
RAS p21 protein activator (GTPase activating protein) 1
|
|
RASGRF1
|
Ras protein-specific guanine nucleotide-releasing factor 1
|
|
RASGRF2
|
Ras protein-specific guanine nucleotide-releasing factor 2
|
|
RASGRP1
|
RAS guanyl releasing protein 1 (calcium and DAG-regulated)
|
|
RASGRP3
|
RAS guanyl releasing protein 3 (calcium and DAG-regulated)
|
|
RASSF1
|
Ras association (RalGDS/AF-6) domain family member 1
|
|
RB1
|
retinoblastoma 1
|
|
RDX
|
radixin
|
|
RET
|
ret proto-oncogene
|
|
RHEB
|
Ras homolog enriched in brain
|
|
RICTOR
|
RPTOR independent companion of MTOR, complex 2
|
|
RIN1
|
Ras and Rab interactor 1
|
|
RND3
|
Rho family GTPase 3
|
|
RPS6
|
ribosomal protein S6
|
|
RPS6KA1
|
ribosomal protein S6 kinase, 90kDa, polypeptide 1
|
|
RPS6KB1
|
ribosomal protein S6 kinase, 70kDa, polypeptide 1
|
|
RPTOR
|
regulatory associated protein of MTOR, complex 1
|
|
RRAS
|
related RAS viral (r-ras) oncogene homolog
|
|
RXRA
|
retinoid X receptor, alpha
|
|
SDC2
|
syndecan 2
|
|
SH2D3C
|
SH2 domain containing 3C
|
|
SHC1
|
SHC (Src homology 2 domain containing) transforming protein 1
|
|
SLAMF1
|
signaling lymphocytic activation molecule family member 1
|
|
SMAD2
|
SMAD family member 2
|
|
SMAD3
|
SMAD family member 3
|
|
SOS1
|
son of sevenless homolog 1 (Drosophila)
|
|
SP1
|
Sp1 transcription factor
|
|
SRC
|
SRC proto-oncogene, non-receptor tyrosine kinase
|
|
SSH1
|
slingshot protein phosphatase 1
|
|
STAT1
|
signal transducer and activator of transcription 1, 91kDa
|
|
STAT3
|
signal transducer and activator of transcription 3 (acute-phase response factor)
|
|
STAT5A
|
signal transducer and activator of transcription 5A
|
|
STK3
|
serine/threonine kinase 3
|
|
SYNGAP1
|
synaptic Ras GTPase activating protein 1
|
|
TP53
|
tumor protein p53
|
|
TSC2
|
tuberous sclerosis 2
|
|
TWIST1
|
twist family bHLH transcription factor 1
|
|
VASP
|
vasodilator-stimulated phosphoprotein
|
|
ZAP70
|
zeta-chain (TCR) associated protein kinase 70kDa
|
